Suchergebnisse - "Govoni, Marinella"

PubPharm (30)

1

Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy : a pooled analysis of European prospective observational studie

enthalten in: Clinical and experimental rheumatology | 2024

von Govoni, M. | Batalov, A. | Boumpas, D. | +6

2

Long-term golimumab persistence : Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

enthalten in: Clinical rheumatology | 2023

von Weinstein, C. | Meehan, A. | Lin, J. | +2

3

Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

enthalten in: Clinical rheumatology | 2023

von Weinstein, C. | Meehan, A. | Lin, J. | +2

4

Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis : Data From the PURSUIT Maintenance and Long-Term Extension Studies

enthalten in: Crohn's & colitis 360 | 2023

von Weinstein, C. | Meehan, A. | Govoni, M. | +2

5

Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis : results from GO OBSERVE, a real-world European observational study

enthalten in: European journal of gastroenterology & hepatology | 2022

von Ferrante, M. | Schirbel, A. | Pierik, M. | +7

6

Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort

enthalten in: International journal of rheumatic diseases | 2019

von Claudepierre, P. | Van den Bosch, F. | Sarzi-Puttini, P. | +3

7

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe : a systematic literature review

enthalten in: BMJ open | 2019

von Luttropp, K. | Dozier, M. | Justo, N. | +6

8

Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population : the QUO-VADIS study

enthalten in: Clinical and experimental rheumatology | 2019

von Van den Bosch, F. | Flipo, R. | Braun, J. | +3

9

Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO‐VADIS study, a large, prospective real‐life cohort

enthalten in: International Journal of Rheumatic Diseases | 2019

von Claudepierre, P. | Van den Bosch, F. | Sarzi‐Puttini, P. | +3

10

Correction to : Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial

enthalten in: Clinical rheumatology | 2018

von Durez, P. | Pavelka, K. | Lazaro, M. | +5

ErratumFor: Clin Rheumatol. 2018 May;37(5):1417-1420. - PMID 29611083